199 related articles for article (PubMed ID: 28166431)
1. Change in HbA1c associated with treatment intensification among patients with type 2 diabetes and poor glycemic control.
Fu AZ; Sheehan JJ
Curr Med Res Opin; 2017 May; 33(5):853-858. PubMed ID: 28166431
[TBL] [Abstract][Full Text] [Related]
2. Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 Diabetes.
Desai U; Kirson NY; Kim J; Khunti K; King S; Trieschman E; Hellstern M; Hunt PR; Mukherjee J
Diabetes Care; 2018 Oct; 41(10):2096-2104. PubMed ID: 30131396
[TBL] [Abstract][Full Text] [Related]
3. Impact of time to treatment intensification on glycemic goal attainment among patients with type 2 diabetes failing metformin monotherapy.
Rajpathak SN; Rajgopalan S; Engel SS
J Diabetes Complications; 2014; 28(6):831-5. PubMed ID: 25104238
[TBL] [Abstract][Full Text] [Related]
4. Treatment intensification for patients with type 2 diabetes and poor glycaemic control.
Fu AZ; Sheehan JJ
Diabetes Obes Metab; 2016 Sep; 18(9):892-8. PubMed ID: 27160505
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the relationship between diabetes treatment intensification and quality measure performance using electronic medical records.
Arnold RJG; Yang S; Gold EJ; Farahbakhshian S; Sheehan JJ
PLoS One; 2018; 13(6):e0199011. PubMed ID: 29894495
[TBL] [Abstract][Full Text] [Related]
6. Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes.
Mocarski M; Yeaw J; Divino V; DeKoven M; Guerrero G; Langer J; Thorsted BL
J Manag Care Spec Pharm; 2018 Apr; 24(4):390-400. PubMed ID: 29406841
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal changes in glycated haemoglobin following treatment intensification after inadequate response to two oral antidiabetic agents in patients with type 2 diabetes.
Kim K; Unni S; Brixner DI; Thomas SM; Olsen CJ; Sterling KL; Mitchell M; McAdam-Marx C
Diabetes Obes Metab; 2019 Jul; 21(7):1725-1733. PubMed ID: 30848039
[TBL] [Abstract][Full Text] [Related]
8. Use of Add-on Treatment to Metformin Monotherapy for Patients with Type 2 Diabetes and Suboptimal Glycemic Control: A U.S. Database Study.
Yu S; Schwab P; Bian B; Radican L; Tunceli K
J Manag Care Spec Pharm; 2016 Mar; 22(3):272-80. PubMed ID: 27003557
[TBL] [Abstract][Full Text] [Related]
9. Influence of Treatment Intensification on A1c in Patients with Suboptimally Controlled Type 2 Diabetes After 2 Oral Antidiabetic Agents.
Kim K; Unni S; McAdam-Marx C; Thomas SM; Sterling KL; Olsen CJ; Johnstone B; Mitchell M; Brixner D
J Manag Care Spec Pharm; 2019 Mar; 25(3):314-322. PubMed ID: 30816811
[TBL] [Abstract][Full Text] [Related]
10. Distance to glycemic goal at the time of treatment intensification in patients with type 2 diabetes mellitus failing metformin monotherapy in the United States.
Fernandes G; Sawhney B; Hannachi H; Liu J; Wang T; Fu AZ; Iglay K; McNeill A; Rajpathak S
Curr Med Res Opin; 2020 May; 36(5):741-748. PubMed ID: 31990206
[No Abstract] [Full Text] [Related]
11. Factors Associated with Diabetes-Related Clinical Inertia in a Managed Care Population and Its Effect on Hemoglobin A1c Goal Attainment: A Claims-Based Analysis.
Ruiz-Negrón N; Wander C; McAdam-Marx C; Pesa J; Bailey RA; Bellows BK
J Manag Care Spec Pharm; 2019 Mar; 25(3):304-313. PubMed ID: 30816810
[TBL] [Abstract][Full Text] [Related]
12. Intensification of antihyperglycemic therapy among patients with incident diabetes: a Surveillance Prevention and Management of Diabetes Mellitus (SUPREME-DM) study.
Raebel MA; Ellis JL; Schroeder EB; Xu S; O'Connor PJ; Segal JB; Butler MG; Schmittdiel JA; Kirchner HL; Goodrich GK; Lawrence JM; Nichols GA; Newton KM; Pathak RD; Steiner JF
Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):699-710. PubMed ID: 24639086
[TBL] [Abstract][Full Text] [Related]
13. Consequences of delaying treatment intensification in type 2 diabetes: evidence from a UK database.
Watson L; Das R; Farquhar R; Langerman H; Barnett AH
Curr Med Res Opin; 2016 Sep; 32(9):1465-75. PubMed ID: 26907851
[TBL] [Abstract][Full Text] [Related]
14. Impact of delaying treatment intensification with a glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes uncontrolled on basal insulin: A longitudinal study of a US administrative claims database.
Tong L; Pan C; Wang H; Bertolini M; Lew E; Meneghini LF
Diabetes Obes Metab; 2018 Apr; 20(4):831-839. PubMed ID: 29119712
[TBL] [Abstract][Full Text] [Related]
15. Use of an Electronic Medical Record (EMR) to Identify Glycemic Intensification Strategies in Type 2 Diabetes.
Korytkowski MT; Brooks M; Lombardero M; DeAlmeida D; Kanter J; Magaji V; Orchard T; Siminerio L
J Diabetes Sci Technol; 2015 May; 9(3):593-601. PubMed ID: 25526759
[TBL] [Abstract][Full Text] [Related]
16. Impact of Timely Treatment Intensification on Glycemic Goal Achievement in Patients With Type 2 Diabetes Failing Metformin Monotherapy.
Mahabaleshwarkar R; Templin M; Gohs F; Mulder H; DeSantis A; Ejzykowicz F; Rajpathak S; Wilkins N
Diabetes Educ; 2017 Oct; 43(5):495-505. PubMed ID: 28828933
[TBL] [Abstract][Full Text] [Related]
17. Diabetes treatment intensification and associated changes in HbA1c and body mass index: a cohort study.
Roumie CL; Greevy RA; Grijalva CG; Hung AM; Liu X; Griffin MR
BMC Endocr Disord; 2016 Jun; 16(1):32. PubMed ID: 27255309
[TBL] [Abstract][Full Text] [Related]
18. Determinants of Glycemic Response to Add-On Therapy with a Dipeptidyl Peptidase-4 Inhibitor: A Retrospective Cohort Study Using a United Kingdom Primary Care Database.
Mamza J; Mehta R; Donnelly R; Idris I
Diabetes Technol Ther; 2016 Feb; 18(2):85-92. PubMed ID: 26752504
[TBL] [Abstract][Full Text] [Related]
19. Comparative Effectiveness of Metformin Dosage Uptitration Versus Adding Another Antihyperglycemic Medication on Glycemic Control in Type 2 Diabetes Patients Failing Initial Metformin Monotherapy: A Retrospective Cohort Study.
Mahabaleshwarkar R; Liu TL; Mulder H
Popul Health Manag; 2019 Oct; 22(5):457-463. PubMed ID: 30628868
[TBL] [Abstract][Full Text] [Related]
20. Intensification of Diabetes Therapy and Time Until A1C Goal Attainment Among Patients With Newly Diagnosed Type 2 Diabetes Who Fail Metformin Monotherapy Within a Large Integrated Health System.
Pantalone KM; Wells BJ; Chagin KM; Ejzykowicz F; Yu C; Milinovich A; Bauman JM; Kattan MW; Rajpathak S; Zimmerman RS
Diabetes Care; 2016 Sep; 39(9):1527-34. PubMed ID: 27519447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]